ID   IL21_HUMAN              Reviewed;         162 AA.
AC   Q9HBE4; A5J0L4;
DT   23-NOV-2004, integrated into UniProtKB/Swiss-Prot.
DT   10-APR-2019, sequence version 3.
DT   07-APR-2021, entry version 152.
DE   RecName: Full=Interleukin-21 {ECO:0000305};
DE            Short=IL-21;
DE   AltName: Full=Za11;
DE   Flags: Precursor;
GN   Name=IL21 {ECO:0000312|HGNC:HGNC:6005};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=11081504; DOI=10.1038/35040504;
RA   Parrish-Novak J., Dillon S.R., Nelson A., Hammond A., Sprecher C.,
RA   Gross J.A., Johnston J., Madden K., Xu W., West J., Schrader S.,
RA   Burkhead S., Heipel M., Brandt C., Kuijper J.L., Kramer J., Conklin D.,
RA   Presnell S.R., Berry J., Shiota F., Bort S., Hambly K., Mudri S., Clegg C.,
RA   Moore M., Grant F.J., Lofton-Day C., Gilbert T., Raymond F., Ching A.,
RA   Yao L., Smith D., Webster P., Whitmore T., Maurer M., Kaushansky K.,
RA   Holly R.D., Foster D.;
RT   "Interleukin 21 and its receptor are involved in NK cell expansion and
RT   regulation of lymphocyte function.";
RL   Nature 408:57-63(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=17673207; DOI=10.1016/j.febslet.2007.07.034;
RA   Rahman M., Nara H., Onoda T., Araki A., Li J., Hoshino T., Asao H.;
RT   "Cloning and characterization of an isoform of interleukin-21.";
RL   FEBS Lett. 581:4001-4009(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   SeattleSNPs variation discovery resource;
RL   Submitted (SEP-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION.
RX   PubMed=15178704; DOI=10.1189/jlb.1003488;
RA   Strengell M., Julkunen I., Matikainen S.;
RT   "IFN-alpha regulates IL-21 and IL-21R expression in human NK and T cells.";
RL   J. Leukoc. Biol. 76:416-422(2004).
RN   [7]
RP   REVIEW.
RX   PubMed=15147560; DOI=10.1111/j.1365-2567.2004.01886.x;
RA   Sivakumar P.V., Foster D.C., Clegg C.H.;
RT   "Interleukin-21 is a T-helper cytokine that regulates humoral immunity and
RT   cell-mediated anti-tumour responses.";
RL   Immunology 112:177-182(2004).
RN   [8]
RP   STRUCTURE BY NMR OF 30-162, AND DISULFIDE BONDS.
RX   PubMed=17565991; DOI=10.1074/jbc.m701313200;
RA   Bondensgaard K., Breinholt J., Madsen D., Omkvist D.H., Kang L.,
RA   Worsaae A., Becker P., Schioedt C.B., Hjorth S.A.;
RT   "The existence of multiple conformers of interleukin-21 directs engineering
RT   of a superpotent analogue.";
RL   J. Biol. Chem. 282:23326-23336(2007).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 30-162 IN COMPLEX WITH IL21R, AND
RP   DISULFIDE BONDS.
RX   PubMed=22235133; DOI=10.1074/jbc.m111.311084;
RA   Hamming O.J., Kang L., Svensson A., Karlsen J.L., Rahbek-Nielsen H.,
RA   Paludan S.R., Hjorth S.A., Bondensgaard K., Hartmann R.;
RT   "Crystal structure of interleukin-21 receptor (IL-21R) bound to IL-21
RT   reveals that sugar chain interacting with WSXWS motif is integral part of
RT   IL-21R.";
RL   J. Biol. Chem. 287:9454-9460(2012).
RN   [10]
RP   VARIANT CVID11 PRO-56, AND CHARACTERIZATION OF VARIANT CVID11 PRO-56.
RX   PubMed=24746753; DOI=10.1016/j.jaci.2014.02.034;
RA   Salzer E., Kansu A., Sic H., Majek P., Ikinciogullari A., Dogu F.E.,
RA   Prengemann N.K., Santos-Valente E., Pickl W.F., Bilic I., Ban S.A.,
RA   Kuloglu Z., Demir A.M., Ensari A., Colinge J., Rizzi M., Eibel H.,
RA   Boztug K.;
RT   "Early-onset inflammatory bowel disease and common variable
RT   immunodeficiency-like disease caused by IL-21 deficiency.";
RL   J. Allergy Clin. Immunol. 133:1651-1660(2014).
CC   -!- FUNCTION: Cytokine with immunoregulatory activity. May promote the
CC       transition between innate and adaptive immunity. Induces the production
CC       of IgG(1) and IgG(3) in B-cells (By similarity). Implicated in the
CC       generation and maintenance of T follicular helper (Tfh) cells and the
CC       formation of germinal-centers. Together with IL6, control the early
CC       generation of Tfh cells and are critical for an effective antibody
CC       response to acute viral infection (By similarity). May play a role in
CC       proliferation and maturation of natural killer (NK) cells in synergy
CC       with IL15. May regulate proliferation of mature B- and T-cells in
CC       response to activating stimuli. In synergy with IL15 and IL18
CC       stimulates interferon gamma production in T-cells and NK cells
CC       (PubMed:11081504, PubMed:15178704). During T-cell mediated immune
CC       response may inhibit dendritic cells (DC) activation and maturation (By
CC       similarity). {ECO:0000250|UniProtKB:Q9ES17,
CC       ECO:0000269|PubMed:11081504, ECO:0000269|PubMed:15178704}.
CC   -!- INTERACTION:
CC       Q9HBE4; Q12797-6: ASPH; NbExp=3; IntAct=EBI-6595560, EBI-12092171;
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:11081504}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9HBE4-1; Sequence=Displayed;
CC       Name=2; Synonyms=IL-21iso;
CC         IsoId=Q9HBE4-2; Sequence=VSP_030129;
CC   -!- TISSUE SPECIFICITY: Expressed in activated CD4-positive T-cells but not
CC       in CD8-positive T-cells, B-cells, or monocytes.
CC       {ECO:0000269|PubMed:11081504}.
CC   -!- DISEASE: Immunodeficiency, common variable, 11 (CVID11) [MIM:615767]: A
CC       primary immunodeficiency characterized by antibody deficiency,
CC       hypogammaglobulinemia, recurrent bacterial infections and an inability
CC       to mount an antibody response to antigen. The defect results from a
CC       failure of B-cell differentiation and impaired secretion of
CC       immunoglobulins; the numbers of circulating B-cells is usually in the
CC       normal range, but can be low. {ECO:0000269|PubMed:24746753}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the IL-15/IL-21 family. {ECO:0000305}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-8 is the initiator.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/il21/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF254069; AAG29348.1; -; mRNA.
DR   EMBL; DQ645417; ABG36529.1; -; mRNA.
DR   EMBL; AY763518; AAU88182.1; -; Genomic_DNA.
DR   EMBL; AC053545; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC066258; AAH66258.1; -; mRNA.
DR   EMBL; BC066259; AAH66259.1; -; mRNA.
DR   EMBL; BC066260; AAH66260.1; -; mRNA.
DR   EMBL; BC066261; AAH66261.1; -; mRNA.
DR   EMBL; BC066262; AAH66262.1; -; mRNA.
DR   EMBL; BC069124; AAH69124.1; -; mRNA.
DR   CCDS; CCDS3727.1; -. [Q9HBE4-1]
DR   CCDS; CCDS75189.1; -. [Q9HBE4-2]
DR   RefSeq; NP_001193935.1; NM_001207006.2. [Q9HBE4-2]
DR   RefSeq; NP_068575.1; NM_021803.3. [Q9HBE4-1]
DR   PDB; 2OQP; NMR; -; A=30-162.
DR   PDB; 3TGX; X-ray; 2.80 A; B/D/F/H/J/L/N/P=30-162.
DR   PDBsum; 2OQP; -.
DR   PDBsum; 3TGX; -.
DR   SMR; Q9HBE4; -.
DR   BioGRID; 121857; 6.
DR   IntAct; Q9HBE4; 4.
DR   MINT; Q9HBE4; -.
DR   STRING; 9606.ENSP00000264497; -.
DR   GlyGen; Q9HBE4; 1 site.
DR   iPTMnet; Q9HBE4; -.
DR   PhosphoSitePlus; Q9HBE4; -.
DR   BioMuta; IL21; -.
DR   DMDM; 55976599; -.
DR   PaxDb; Q9HBE4; -.
DR   PeptideAtlas; Q9HBE4; -.
DR   PRIDE; Q9HBE4; -.
DR   ProteomicsDB; 81533; -. [Q9HBE4-1]
DR   ProteomicsDB; 81534; -. [Q9HBE4-2]
DR   ABCD; Q9HBE4; 14 sequenced antibodies.
DR   Antibodypedia; 15937; 879 antibodies.
DR   DNASU; 59067; -.
DR   Ensembl; ENST00000611104; ENSP00000477555; ENSG00000138684. [Q9HBE4-2]
DR   Ensembl; ENST00000648588; ENSP00000497915; ENSG00000138684. [Q9HBE4-1]
DR   GeneID; 59067; -.
DR   KEGG; hsa:59067; -.
DR   UCSC; uc003ies.4; human. [Q9HBE4-1]
DR   CTD; 59067; -.
DR   DisGeNET; 59067; -.
DR   GeneCards; IL21; -.
DR   HGNC; HGNC:6005; IL21.
DR   HPA; ENSG00000138684; Tissue enriched (lymphoid).
DR   MalaCards; IL21; -.
DR   MIM; 605384; gene.
DR   MIM; 615767; phenotype.
DR   neXtProt; NX_Q9HBE4; -.
DR   OpenTargets; ENSG00000138684; -.
DR   Orphanet; 477661; IL21-related infantile inflammatory bowel disease.
DR   PharmGKB; PA29820; -.
DR   VEuPathDB; HostDB:ENSG00000138684.7; -.
DR   eggNOG; ENOG502SES1; Eukaryota.
DR   GeneTree; ENSGT00390000010494; -.
DR   HOGENOM; CLU_127182_1_0_1; -.
DR   InParanoid; Q9HBE4; -.
DR   OMA; HCEWSAF; -.
DR   OrthoDB; 1439856at2759; -.
DR   PhylomeDB; Q9HBE4; -.
DR   TreeFam; TF336380; -.
DR   PathwayCommons; Q9HBE4; -.
DR   Reactome; R-HSA-9020958; Interleukin-21 signaling.
DR   SignaLink; Q9HBE4; -.
DR   SIGNOR; Q9HBE4; -.
DR   BioGRID-ORCS; 59067; 4 hits in 974 CRISPR screens.
DR   EvolutionaryTrace; Q9HBE4; -.
DR   GeneWiki; Interleukin_21; -.
DR   GenomeRNAi; 59067; -.
DR   Pharos; Q9HBE4; Tbio.
DR   PRO; PR:Q9HBE4; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   RNAct; Q9HBE4; protein.
DR   Bgee; ENSG00000138684; Expressed in tonsil and 23 other tissues.
DR   ExpressionAtlas; Q9HBE4; baseline and differential.
DR   Genevisible; Q9HBE4; HS.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; NAS:UniProtKB.
DR   GO; GO:0005125; F:cytokine activity; IEA:UniProtKB-KW.
DR   GO; GO:0005126; F:cytokine receptor binding; TAS:UniProtKB.
DR   GO; GO:0005134; F:interleukin-2 receptor binding; IPI:UniProtKB.
DR   GO; GO:0048469; P:cell maturation; IDA:UniProtKB.
DR   GO; GO:0098586; P:cellular response to virus; ISS:UniProtKB.
DR   GO; GO:0051607; P:defense response to virus; TAS:ARUK-UCL.
DR   GO; GO:0002314; P:germinal center B cell differentiation; ISS:UniProtKB.
DR   GO; GO:0038114; P:interleukin-21-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0030890; P:positive regulation of B cell proliferation; IDA:MGI.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IDA:MGI.
DR   GO; GO:0001819; P:positive regulation of cytokine production; IDA:CACAO.
DR   GO; GO:0002639; P:positive regulation of immunoglobulin production; ISS:UniProtKB.
DR   GO; GO:0050729; P:positive regulation of inflammatory response; IC:BHF-UCL.
DR   GO; GO:0032729; P:positive regulation of interferon-gamma production; NAS:UniProtKB.
DR   GO; GO:0032740; P:positive regulation of interleukin-17 production; IDA:BHF-UCL.
DR   GO; GO:0045954; P:positive regulation of natural killer cell mediated cytotoxicity; IDA:CACAO.
DR   GO; GO:0042102; P:positive regulation of T cell proliferation; IDA:UniProtKB.
DR   GO; GO:0034105; P:positive regulation of tissue remodeling; IC:BHF-UCL.
DR   GO; GO:0042531; P:positive regulation of tyrosine phosphorylation of STAT protein; IDA:MGI.
DR   GO; GO:0007165; P:signal transduction; NAS:UniProtKB.
DR   GO; GO:0061470; P:T follicular helper cell differentiation; ISS:UniProtKB.
DR   GO; GO:0007260; P:tyrosine phosphorylation of STAT protein; IDA:CACAO.
DR   Gene3D; 1.20.1250.70; -; 1.
DR   InterPro; IPR009079; 4_helix_cytokine-like_core.
DR   InterPro; IPR003443; IL-15/IL-21_fam.
DR   InterPro; IPR038327; IL-15/IL-21_sf.
DR   PANTHER; PTHR14356; PTHR14356; 1.
DR   Pfam; PF02372; IL15; 1.
DR   SUPFAM; SSF47266; SSF47266; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cytokine; Disease variant;
KW   Disulfide bond; Glycoprotein; Reference proteome; Secreted; Signal.
FT   SIGNAL          1..24
FT                   /evidence="ECO:0000250|UniProtKB:Q76LU5"
FT   CHAIN           25..162
FT                   /note="Interleukin-21"
FT                   /id="PRO_0000015505"
FT   CARBOHYD        97
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        71..122
FT                   /evidence="ECO:0000269|PubMed:17565991,
FT                   ECO:0000269|PubMed:22235133, ECO:0000312|PDB:2OQP,
FT                   ECO:0000312|PDB:3TGX"
FT   DISULFID        78..125
FT                   /evidence="ECO:0000269|PubMed:17565991,
FT                   ECO:0000269|PubMed:22235133, ECO:0000312|PDB:2OQP,
FT                   ECO:0000312|PDB:3TGX"
FT   VAR_SEQ         147..162
FT                   /note="MIHQHLSSRTHGSEDS -> VSTLSFI (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:17673207"
FT                   /id="VSP_030129"
FT   VARIANT         56
FT                   /note="L -> P (in CVID11; interferes with binding to
FT                   IL21R)"
FT                   /evidence="ECO:0000269|PubMed:24746753"
FT                   /id="VAR_071292"
FT   HELIX           32..49
FT                   /evidence="ECO:0007744|PDB:3TGX"
FT   HELIX           50..55
FT                   /evidence="ECO:0007744|PDB:3TGX"
FT   HELIX           69..71
FT                   /evidence="ECO:0007744|PDB:3TGX"
FT   HELIX           72..81
FT                   /evidence="ECO:0007744|PDB:3TGX"
FT   HELIX           92..103
FT                   /evidence="ECO:0007744|PDB:3TGX"
FT   STRAND          108..112
FT                   /evidence="ECO:0007744|PDB:2OQP"
FT   STRAND          114..116
FT                   /evidence="ECO:0007744|PDB:2OQP"
FT   STRAND          120..122
FT                   /evidence="ECO:0007744|PDB:3TGX"
FT   TURN            125..127
FT                   /evidence="ECO:0007744|PDB:3TGX"
FT   HELIX           133..149
FT                   /evidence="ECO:0007744|PDB:3TGX"
SQ   SEQUENCE   162 AA;  18653 MW;  54EFD4EED3AB97FE CRC64;
     MRSSPGNMER IVICLMVIFL GTLVHKSSSQ GQDRHMIRMR QLIDIVDQLK NYVNDLVPEF
     LPAPEDVETN CEWSAFSCFQ KAQLKSANTG NNERIINVSI KKLKRKPPST NAGRRQKHRL
     TCPSCDSYEK KPPKEFLERF KSLLQKMIHQ HLSSRTHGSE DS
//
